Simulations Plus Free Cash Flow 2010-2024 | SLP
Simulations Plus free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Simulations Plus Annual Free Cash Flow |
| 2024 |
9.56 |
| 2023 |
18.18 |
| 2022 |
13.93 |
| 2021 |
14.63 |
| 2020 |
8.33 |
| 2019 |
9.73 |
| 2018 |
6.96 |
| 2017 |
5.32 |
| 2016 |
4.18 |
| 2015 |
5.90 |
| 2014 |
3.91 |
| 2013 |
1.38 |
| 2012 |
4.69 |
| 2011 |
2.68 |
| 2010 |
1.97 |
| 2009 |
1.78 |
| Simulations Plus Quarterly Free Cash Flow |
| 2024-08-31 |
9.56 |
| 2024-05-31 |
53.76 |
| 2024-02-29 |
3.82 |
| 2023-11-30 |
-0.69 |
| 2023-08-31 |
18.18 |
| 2023-05-31 |
15.99 |
| 2023-02-28 |
8.26 |
| 2022-11-30 |
3.70 |
| 2022-08-31 |
13.93 |
| 2022-05-31 |
6.97 |
| 2022-02-28 |
3.96 |
| 2021-11-30 |
2.18 |
| 2021-08-31 |
14.63 |
| 2021-05-31 |
7.69 |
| 2021-02-28 |
4.58 |
| 2020-11-30 |
4.40 |
| 2020-08-31 |
8.33 |
| 2020-05-31 |
4.27 |
| 2020-02-29 |
2.63 |
| 2019-11-30 |
2.10 |
| 2019-08-31 |
9.73 |
| 2019-05-31 |
6.08 |
| 2019-02-28 |
4.72 |
| 2018-11-30 |
2.25 |
| 2018-08-31 |
6.96 |
| 2018-05-31 |
4.06 |
| 2018-02-28 |
2.86 |
| 2017-11-30 |
2.09 |
| 2017-08-31 |
5.32 |
| 2017-05-31 |
3.72 |
| 2017-02-28 |
1.03 |
| 2016-11-30 |
1.65 |
| 2016-08-31 |
4.18 |
| 2016-05-31 |
1.90 |
| 2016-02-29 |
0.11 |
| 2015-11-30 |
-0.63 |
| 2015-08-31 |
5.90 |
| 2015-05-31 |
2.93 |
| 2015-02-28 |
1.06 |
| 2014-11-30 |
-0.09 |
| 2014-08-31 |
3.91 |
| 2014-05-31 |
2.26 |
| 2014-02-28 |
0.90 |
| 2013-11-30 |
0.97 |
| 2013-08-31 |
1.38 |
| 2013-05-31 |
0.73 |
| 2013-02-28 |
-0.01 |
| 2012-11-30 |
-0.53 |
| 2012-08-31 |
4.69 |
| 2012-05-31 |
4.06 |
| 2012-02-29 |
2.87 |
| 2011-11-30 |
2.48 |
| 2011-08-31 |
2.43 |
| 2011-05-31 |
2.37 |
| 2011-02-28 |
1.15 |
| 2010-11-30 |
0.47 |
| 2010-08-31 |
1.97 |
| 2010-05-31 |
1.91 |
| 2010-02-28 |
1.38 |
| 2009-11-30 |
0.74 |
| 2009-08-31 |
1.78 |
| 2009-05-31 |
1.09 |
| 2009-02-28 |
1.11 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.580B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
